Topic

New Jersey

A collection of 536 issues

How to Get Cimzia (Certolizumab Pegol) Covered by Humana in New Jersey: PA Forms, ICD-10 Codes, and Appeals Guide

Answer Box: Getting Cimzia Covered by Humana in New Jersey Cimzia (certolizumab pegol) requires prior authorization from Humana across all plan types in New Jersey. The fastest path to approval: submit PA with specific ICD-10 codes (M06.9 for RA, K50.9 for Crohn's), documented step therapy failures,

How to Get Xenpozyme (Olipudase Alfa) Covered by Blue Cross Blue Shield in New Jersey: Complete 2025 Timeline Guide

Answer Box: Getting Xenpozyme Covered in New Jersey Xenpozyme requires prior authorization through Horizon Blue Cross Blue Shield of New Jersey's Medical Injectables Program. Standard approval takes 72 hours with complete documentation (genetic testing confirming SMPD1 mutation, baseline organ assessments). If denied, you have 180 days to file

How to Get Adynovate (Bdanocog Alfa Pegol) Covered by Humana in New Jersey: Decision Tree & Appeal Guide

Answer Box: Getting Adynovate Covered by Humana in New Jersey Adynovate (bdanocog alfa pegol) requires prior authorization from Humana for hemophilia A treatment. You're likely eligible if you have confirmed Factor VIII deficiency <40% with documented bleeding episodes. First step today: Request your complete denial letter if

The Complete Requirements Checklist to Get Jakafi (ruxolitinib) Covered by UnitedHealthcare in New Jersey: Forms, Appeals, and Timeline

Answer Box: Getting Jakafi Covered in New Jersey UnitedHealthcare requires prior authorization for Jakafi (ruxolitinib) through OptumRx with specific clinical criteria for myelofibrosis, polycythemia vera, and GVHD. In New Jersey, if denied, you have 180 days for internal appeals, then external review through Maximus (IHCAP). First step today: Gather your

How to Get Xyrem (Sodium Oxybate) Covered by Aetna CVS Health in New Jersey: Complete Prior Authorization Guide

Answer Box: Your Fastest Path to Xyrem Coverage To get Xyrem (sodium oxybate) covered by Aetna CVS Health in New Jersey, you need: (1) confirmed narcolepsy diagnosis with sleep study results, (2) documented failure of stimulants/modafinil (unless contraindicated), and (3) REMS enrollment. Submit prior authorization via CVS Caremark at

Complete Requirements Checklist to Get Mavenclad (Cladribine Tablets) Covered by UnitedHealthcare in New Jersey: Forms, Timelines, and Appeal Process

Answer Box: Getting Mavenclad Covered by UnitedHealthcare in New Jersey UnitedHealthcare requires prior authorization for Mavenclad (cladribine tablets) through OptumRx, with step therapy requiring documented failure of at least one other MS disease-modifying therapy. Submit electronically via the UnitedHealthcare Provider Portal with complete clinical documentation for 24-72 hour processing. If

How to Get Strensiq (Asfotase Alfa) Covered by UnitedHealthcare in New Jersey: Complete Prior Authorization Guide with Appeals

Quick Answer: UnitedHealthcare covers Strensiq (asfotase alfa) for pediatric-onset hypophosphatasia through OptumRx with prior authorization. Submit PA documentation including diagnosis confirmation, low alkaline phosphatase levels, and specialist prescription. If denied, you have 60 days for internal appeals and 4 months for New Jersey's external review through Maximus Federal

Lowering Out-of-Pocket for Signifor / Signifor LAR (pasireotide) with UnitedHealthcare in New Jersey: Copay, Tiering & Assistance

Quick Answer: Reducing Your Signifor LAR Costs with UnitedHealthcare in New Jersey UnitedHealthcare requires prior authorization for Signifor LAR (pasireotide) with potential high specialty tier costs. Key cost-reduction strategies include the manufacturer's $20 copay program for commercial insurance, foundation grants up to $13,600/year, and formulary tier

How to Get Alprolix Covered by UnitedHealthcare in New Jersey: PA Forms, Appeals, and State Resources

Answer Box: Getting Alprolix Covered by UnitedHealthcare in New Jersey UnitedHealthcare requires prior authorization (PA) for Alprolix through OptumRx, with coverage contingent on confirmed hemophilia B diagnosis, hematologist prescription, and documented failure of standard half-life factor IX therapy (≥50 exposure days). Submit PA via the UnitedHealthcare Provider Portal with medical

Humana's Coverage Criteria for Hemlibra (emicizumab-kxwh) in New Jersey: What Counts as "Medically Necessary"?

Answer Box: Getting Hemlibra Covered by Humana in New Jersey Hemlibra (emicizumab-kxwh) requires prior authorization from Humana Medicare plans with specific medical necessity criteria: confirmed hemophilia A diagnosis (ICD-10 D66), documented factor VIII inhibitor status (≥5 Bethesda units), bleeding history, and weight-based dosing plan. Submit through Humana's provider